Log In
Print
BCIQ
Print
Print this Print this
 

Lidoderm, lidocaine

  Manage Alerts
Collapse Summary General Information
Company Endo International plc
DescriptionLidocaine patch 5%
Molecular Target Sodium channel
Mechanism of ActionNa channel blocker
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsTreat chronic low back pain; Treat pain associated with mild to moderate carpal tunnel syndrome (CTS); Treat pain associated with osteoarthritis (OA) of the knee; Treat pain associated with post-herpetic neuralgia (PHN)
Regulatory Designation

Partner

Teikoku Seiyaku Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today